BAP1 and neoplasm: To gain insight in the molecular consequences of EZH2 inhibition and the increased sensitivity to the combination in BAP1 depleted cells, we performed RNA sequencing (RNA-seq) on primary tumor cell lines treated with EZH2 inhibitor.